Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications

Figure 1

Management of immunogenicity in preclinical and clinical settings. ADAs: anti-drug antibodies; APC: antigen presenting cell; ELISA: enzyme-linked immunosorbent assay; CLBA: competitive ligand binding assay.